2015~2020年东莞地区小剂量成分血临床使用现状和趋势分析  

Current status and trend analysis of clinical use of low-dose blood components,from 2015 to 2020 in Dongguan

作　　者：张春莲 陈少彬[2] 何子毅[2] 陈庆恺[2] 李姗丹[2] ZHANG Chunlian;CHEN Shaobin;HE Ziyi;CHEN Qingkai;LI Shandan(Department of Neonatology,Dongguan Tungwah Hospital,Dongguan 523110,China;Dongguan Blood Center)

机构地区：[1]东莞东华医院新生儿科,广东东莞523110 [2]东莞市中心血站

出　　处：《中国输血杂志》2022年第4期431-434,共4页Chinese Journal of Blood Transfusion

基　　金：东莞市社会科技发展(重点)项目(201950715026187)。

摘　　要：目的回顾分析东莞地区小剂量成分血的临床使用情况,掌握临床儿科用血的变化趋势,为血站更好地实施小剂量成分血的制备和库存管理提供参考。方法统计2015~2020年东莞市中心血站小剂量红细胞类、血小板类和血浆类的临床用血信息,分析不同年份、不同等级或性质医院(公立三甲综合、公立三甲专科、民营三甲、民营三甲管理、区域中心、公立镇级、小型民营)及不同规格制剂(0.25 U、0.5 U)小剂量成分血的分布和变化趋势。结果6年间小剂量红细胞类、血小板类和血浆类的累积增长率分别为10.78%、1098.55%和-29.41%,年复合增长率分别为2.07%、64.34%和-6.73%;不同等级医院的小剂量成分血在红细胞类、血小板类和血浆类的构成比分布不同(P<0.05),其中红细胞类和血浆类在公立三甲专科医院使用数量最多,分别占比45.08%(7272/16133)和53.18%(7199/13373),血小板类在民营三甲管理医院使用数量最多,占总量77.38%(3393/4385),品种以单采血小板53.84%(1144/2125)和辐照单采血小板99.51%(2249/2260)为主;使用0.25 U和0.5 U的红细胞类在不同医院使用的构成比分布不同(P<0.05),其中0.25 U在公立三甲综合医院使用较多,占62.60%(3502/5594),0.5 U在公立三甲专科选择较多,占62.09%(6544/10539)。结论2015~2020年本地区小剂量成分血的临床使用量,血小板类增长显著,红细胞类增长平稳且有波动,血浆类呈逐年下降趋势,其在不同等级医院的使用数量和种类分布不均衡现状与医院儿科的发展定位及新业务开展能力相关,定期监测小剂量成分血用血趋势对保障儿科临床血液供应具有重要意义。Objective To retrospectively analyze the clinical use of low-dose blood components in Dongguan and the trend of clinical pediatric blood use,so as to provide reference for better preparation and inventory management of low-dose blood components in blood centers.Methods The clinical consumption of RBCs,platelets and plasma of Dongguan Blood Center from 2015 to 2020 was counted.The compositions and changes of low-dose blood components by specifications(0.25 U,0.5 U),years and hospitals(public grade A general hospital,public grade A specialized hospital,private grade A hospital,private hospital equivalent to grade A,regional central hospital,public township hospital,small private hospital)were analyzed.Results The cumulative growth rates of low-dose RBCs,platelets,and plasma in 6 years were 10.78%,1098.55%and-29.41%,respectively,and the compound annual growth rates were 2.07%,64.34%and-6.73%,respectively.The composition of low-dose blood components in RBCs,platelets and plasma was different(P<0.05)in different levels of hospitals,among which RBCs and plasma were the mostly used in public grade A specialized hospital,accounting for 45.08%(7272/16133)and 53.18%(7199/13373)respectively,while platelets were the mostly used in private grade A management hospitals,accounting for 77.38%(3393/4385),dominated by apheresis platelets 53.84%(1144/2125)and irradiated apheresis platelets 99.51%(2249/2260).The composition ratios of 0.25 U and 0.5 U RBCs used in different hospitals were significantly different(P<0.05).The 0.25 U RBCs were used mostly in public grade A hospitals(62.60%,3502/5594)and 0.5 U RBCs in public grade A specialized hospitals(62.09%,6544/10539).Conclusion The total consumption of low-dose blood components in clinical pediatrics from 2015 to 2020 were as follows:platelets had increased significantly year by year,RBCs had increased steadily and with fluctuation,plasma had a downward trend year by year.The consumption volume and varieties used in different levels of hospitals were uneven,which may be related to

关 键 词：小剂量成分血 儿科输血 趋势分析 血液制备 临床用血 

分 类 号：R457.1[医药卫生—治疗学]